Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies?
- 30 November 1994
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 21 (8) , 1035-1044
- https://doi.org/10.1016/0969-8051(94)90175-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pharmacokinetics of the FO23C5 anti-CEA antibody fragment labelled with 99Tcm and 111InNuclear Medicine Communications, 1993
- The stability of 99Tcm directly labelled to an Fab' antibody via stannous ion and mercaptoethanol reductionNuclear Medicine Communications, 1992
- Technetium-99m-labeled monoclonal antibodies for immunoscintigraphy: Simplified preparation and evaluationJournal of Immunological Methods, 1991
- High‐dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urineEuropean Journal of Clinical Investigation, 1991
- 99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphyNuclear Medicine Communications, 1989
- BIOCHEMISTRY OF SULFUR-CONTAINING AMINO ACIDSAnnual Review of Biochemistry, 1983
- Radioactive Labeling of Antibody: A Simple and Efficient MethodScience, 1983
- Determination of sulfhydryl groups with 2,2′- or 4,4′-dithiodipyridineArchives of Biochemistry and Biophysics, 1967